Cutler Group LP Omeros Corp Call Options Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$1.92 - $6.28 $384 - $1,256	-200 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$5.07 - $7.2 $139,932 - $198,720	-27,600 Reduced 99.28%	200 $0
Q4 2021 Jan 18, 2022	BUY	$5.67 - $8.54 $19,278 - $29,035	3,400 Added 13.93%	27,800 $1,000
Q3 2021 Oct 26, 2021	BUY	$13.4 - $16.3 $326,960 - $397,720	24,400 New	24,400 $48,000
Q1 2021 Apr 26, 2021	SELL	$14.52 - $23.53 $5,808 - $9,412	-400 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$10.14 - $15.19 $14,196 - $21,266	-1,400 Reduced 77.78%	400 $0
Q3 2020 Oct 27, 2020	BUY	$9.57 - $21.32 $16,269 - $36,244	1,700 Added 1700.0%	1,800 $0
Q1 2018 May 11, 2018	SELL	$9.0 - $20.16 $7,200 - $16,128	-800 Reduced 88.89%	100 $0
Q4 2017 Jan 17, 2018	SELL	$13.26 - $22.86 $246,636 - $425,196	-18,600 Reduced 95.38%	900 $2,000
Q3 2017 Oct 17, 2017	BUY	$19.76 - $24.9 $385,320 - $485,550	19,500	19,500 $64,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.